title: Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
authors.forename: Radovan
authors.initials: R
authors.lastname: Vasko
authors.forename: Frauke
authors.initials: F
authors.lastname: Groenewold
authors.forename: Peter
authors.initials: P
authors.lastname: Korsten
authors.forename: Gerhard A
authors.initials: GA
authors.lastname: Müller
authors.forename: Michael
authors.initials: M
authors.lastname: Koziolek
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008875:Middle Aged; D010956:Plasmapheresis / Q000379:methods*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D000069283:Rituximab; D057049:Thrombotic Microangiopathies / Q000209:etiology / Q000628:therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab